Literature DB >> 9706456

Hepatitis C and depression.

W R Yates1, O Gleason.   

Abstract

Although the incidence of hepatitis C virus (HCV) is declining, a large reservoir of patients with chronic hepatitis C exists. Unless effective HCV antiviral regimens are developed, many patients with asymptomatic HCV will develop clinical symptoms in the next 15 to 20 years. Mood disorders are common in patients with HCV referred for psychiatric consultation. Interferon is the primary treatment for chronic hepatitis C but can induce depression and other mental and neuropsychiatric syndromes. Mood disorders associated with hepatitis C may respond to psychiatric intervention. Psychiatrists need to be aware of the clinical issues in the diagnosis and treatment of depression complicating chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706456     DOI: 10.1002/(sici)1520-6394(1998)7:4<188::aid-da7>3.0.co;2-6

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  17 in total

1.  Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US.

Authors:  Ramsey Cheung; Ajitha Mannalithara; Gurkirpal Singh
Journal:  Dig Dis Sci       Date:  2010-02-26       Impact factor: 3.199

2.  Psychological impact of chronic hepatitis C: comparison with other stressful life events and chronic diseases.

Authors:  Laurent Castera; Aymery Constant; Pierre-Henri Bernard; Victor de Ledinghen; Patrice Couzigou
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

3.  Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial.

Authors:  Benjamin J Morasco; Jennifer M Loftis; David W Indest; Samantha Ruimy; John W Davison; Bradford Felker; Peter Hauser
Journal:  Psychosomatics       Date:  2010 Sep-Oct       Impact factor: 2.386

Review 4.  Neuropsychiatric side effects of interferon-alfa therapy.

Authors:  Arthur R Van Gool; Wim H J Kruit; Frederike K Engels; Gerrit Stoter; Marjolein Bannink; Alexander M M Eggermont
Journal:  Pharm World Sci       Date:  2003-02

5.  Role of inflammatory cytokines in depression: Focus on interleukin-1β.

Authors:  Rai Khalid Farooq; Kashif Asghar; Shahzina Kanwal; Ali Zulqernain
Journal:  Biomed Rep       Date:  2016-11-10

Review 6.  Comorbid medical illness in psychiatric patients.

Authors:  L S Goldman
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

7.  Hepatitis C treatment - better outcomes through partner support.

Authors:  Fleur Chapman; Alexandra McManus
Journal:  Australas Med J       Date:  2012-11-30

8.  The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life.

Authors:  Jeffrey W Kwan; Ruth C Cronkite; Antony Yiu; Mary K Goldstein; Lewis Kazis; Ramsey C Cheung
Journal:  Qual Life Res       Date:  2008-04-22       Impact factor: 4.147

9.  Depression following pegylated interferon-alpha: characteristics and vulnerability.

Authors:  Francis E Lotrich; Mordechai Rabinovitz; Patricia Gironda; Bruce G Pollock
Journal:  J Psychosom Res       Date:  2007-08       Impact factor: 3.006

10.  Mode of transmission, rather than the hepatitis C virus, as a major determinant of poor interpersonal relationships in patients with chronic hepatitis C.

Authors:  T P LA; M Deschênes
Journal:  Can J Gastroenterol       Date:  2007-12       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.